Reference16 articles.
1. Epidemiology and outcome of zygomycosis: a review of 929 reported cases;Roden;Clin Infect Dis: Publ Infect Dis Soc Am,2005
2. Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids;Saghazadeh;Int Immunopharmacol,2020
3. Pakdel F, Mardani M, Salehi M, Khodavaisy S, Tabari A. Practice guideline on prevention, diagnosis, and treatment of rhino-orbito-cerebral mucormycosis in the COVID-19 area: a consensus of iranian experts. Arch Clin Infect Dis; 2022.
4. Rhinocerebral mucormycosis. StatPearls;Bhandari,2022
5. Clinical and microbiological features and outcomes of mucormycosis in critically ill patients;Rothe;Int J Infect Dis: IJID: Publ Int Soc Infect Dis,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amphotericin-B;Reactions Weekly;2023-07-29